PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $45.00
PTC Therapeutics (NASDAQ:PTCT – Free Report) had its target price lifted by Citigroup from $32.00 to $45.00 in a research note released on Wednesday,Benzinga reports. They currently have a sell rating on the biopharmaceutical company’s stock. Other equities analysts have also issued reports about the stock. The Goldman Sachs Group lifted their price objective on […]
PTC Therapeutics (NASDAQ:PTCT – Free Report) had its target price lifted by Citigroup from $32.00 to $45.00 in a research note released on Wednesday,Benzinga reports. They currently have a sell rating on the biopharmaceutical company’s stock. Other equities analysts have also issued reports about the stock. The Goldman Sachs Group lifted their price objective on […]
